<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>煜森资本 | wechat-feeds</title><link>http://MzI3MzcxODkyNQ.favicon.privacyhide.com/favicon.ico</link><description>医疗健康投融资平台  科学家创业平台</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 08 Jun 2021 13:55:07 +0800</pubDate><image><url>http://MzI3MzcxODkyNQ.favicon.privacyhide.com/favicon.ico</url><title>煜森资本 | wechat-feeds</title><link>http://MzI3MzcxODkyNQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>广西！广西！</title><link>https://mp.weixin.qq.com/s/u56fRTLnOMC_n5s8YXqPsA</link><description></description><content:encoded><![CDATA[广西！广西！]]></content:encoded><pubDate>Tue, 08 Jun 2021 11:32:02 +0800</pubDate></item><item><title>百济神州递交抗PD-1抗体第7项适应症上市申请，针对MSI-H或dMMR实体瘤！</title><link>https://mp.weixin.qq.com/s/PmD1kifOiZby4j4VxAwTHA</link><description></description><content:encoded><![CDATA[百济神州递交抗PD-1抗体第7项适应症上市申请，针对MSI-H或dMMR实体瘤！]]></content:encoded><pubDate>Tue, 08 Jun 2021 11:32:02 +0800</pubDate></item><item><title>鼻咽癌一线治疗！恒瑞医药抗PD-1抗体有望迎来新适应症</title><link>https://mp.weixin.qq.com/s/oWkLDT6ZSPX8WqowezgT-w</link><description></description><content:encoded><![CDATA[鼻咽癌一线治疗！恒瑞医药抗PD-1抗体有望迎来新适应症]]></content:encoded><pubDate>Tue, 08 Jun 2021 11:32:02 +0800</pubDate></item><item><title>叮当快药完成新一轮2.2亿美元融资</title><link>https://mp.weixin.qq.com/s/KZX4AeYr-bZWek8wCYUT4A</link><description></description><content:encoded><![CDATA[叮当快药完成新一轮2.2亿美元融资]]></content:encoded><pubDate>Tue, 08 Jun 2021 11:32:02 +0800</pubDate></item><item><title>医疗大健康投融资周报</title><link>https://mp.weixin.qq.com/s/BjL4cH67VebrLQI2te_Mgg</link><description></description><content:encoded><![CDATA[医疗大健康投融资周报]]></content:encoded><pubDate>Tue, 08 Jun 2021 11:32:02 +0800</pubDate></item><item><title>医疗大数据公司医利捷完成首轮融资，软银中国独家领投</title><link>https://mp.weixin.qq.com/s/jTDYefbB07iAsvz2w67kDA</link><description></description><content:encoded><![CDATA[医疗大数据公司医利捷完成首轮融资，软银中国独家领投]]></content:encoded><pubDate>Tue, 08 Jun 2021 11:32:02 +0800</pubDate></item><item><title>亚盛医药Bcl-2抑制剂治疗R/R CLL/SLL最新数据公布：ORR达80%</title><link>https://mp.weixin.qq.com/s/PXNlQejZR_5akcH3qwpUpw</link><description></description><content:encoded><![CDATA[亚盛医药Bcl-2抑制剂治疗R/R CLL/SLL最新数据公布：ORR达80%]]></content:encoded><pubDate>Tue, 08 Jun 2021 11:32:02 +0800</pubDate></item><item><title>国产重组凝血因子VIII临床积极 | 强生FcRn抗体国内报IND...</title><link>https://mp.weixin.qq.com/s/alCChVl47K81fgtNABfJ5w</link><description></description><content:encoded><![CDATA[国产重组凝血因子VIII临床积极 | 强生FcRn抗体国内报IND...]]></content:encoded><pubDate>Tue, 08 Jun 2021 11:32:02 +0800</pubDate></item><item><title>12年磨砺今朝亮剑，祝所有高考学子旗开得胜，梦想成真！</title><link>https://mp.weixin.qq.com/s/3N-vxvktHN_485vhqJQ5tA</link><description></description><content:encoded><![CDATA[12年磨砺今朝亮剑，祝所有高考学子旗开得胜，梦想成真！]]></content:encoded><pubDate>Mon, 07 Jun 2021 14:11:41 +0800</pubDate></item><item><title>基于下一代测序技术的新方法可用于新冠病毒大规模检测</title><link>https://mp.weixin.qq.com/s/3WS6XXFi7qirr2odDxL62w</link><description></description><content:encoded><![CDATA[基于下一代测序技术的新方法可用于新冠病毒大规模检测]]></content:encoded><pubDate>Mon, 07 Jun 2021 14:11:41 +0800</pubDate></item><item><title>康黎医学获近亿元Pre-B轮融资，深耕精神科基因检测赛道</title><link>https://mp.weixin.qq.com/s/DearC3HNASs9I_gI1mRQ_A</link><description></description><content:encoded><![CDATA[康黎医学获近亿元Pre-B轮融资，深耕精神科基因检测赛道]]></content:encoded><pubDate>Mon, 07 Jun 2021 14:11:41 +0800</pubDate></item><item><title>极目生物宣布引进FDA批准干眼治疗器械大中华区、韩国及东盟十国独家权益</title><link>https://mp.weixin.qq.com/s/HNlGH3gLY2Xh8qen0ZwfhA</link><description></description><content:encoded><![CDATA[极目生物宣布引进FDA批准干眼治疗器械大中华区、韩国及东盟十国独家权益]]></content:encoded><pubDate>Mon, 07 Jun 2021 14:11:41 +0800</pubDate></item><item><title>比现有液体活检技术灵敏度高100倍，新锐A轮融资1250万美元</title><link>https://mp.weixin.qq.com/s/vd508-vIWn9WDy1nmxi6-w</link><description></description><content:encoded><![CDATA[比现有液体活检技术灵敏度高100倍，新锐A轮融资1250万美元]]></content:encoded><pubDate>Mon, 07 Jun 2021 14:11:41 +0800</pubDate></item><item><title>葆元/信达公布taletrectinib治疗ROS1融合阳性非小细胞肺癌2期试验初步结果</title><link>https://mp.weixin.qq.com/s/ZZ6p6HenWfByG36uaVBKRA</link><description></description><content:encoded><![CDATA[葆元/信达公布taletrectinib治疗ROS1融合阳性非小细胞肺癌2期试验初步结果]]></content:encoded><pubDate>Mon, 07 Jun 2021 14:11:41 +0800</pubDate></item><item><title>吸入式新冠疫苗国内申请紧急使用 | 诺华心衰药国内获批治疗高血压...</title><link>https://mp.weixin.qq.com/s/krBuvuudpUe6a16D1RgG3g</link><description></description><content:encoded><![CDATA[吸入式新冠疫苗国内申请紧急使用 | 诺华心衰药国内获批治疗高血压...]]></content:encoded><pubDate>Mon, 07 Jun 2021 14:11:41 +0800</pubDate></item><item><title>征祥医药完成2亿元A+轮融资</title><link>https://mp.weixin.qq.com/s/1RHQuBRePuEtAR9nYY9s6g</link><description></description><content:encoded><![CDATA[征祥医药完成2亿元A+轮融资]]></content:encoded><pubDate>Mon, 07 Jun 2021 14:11:41 +0800</pubDate></item><item><title>忽然，想去天津了</title><link>https://mp.weixin.qq.com/s/jL14k9q8TNGbfBt1qLYoZQ</link><description></description><content:encoded><![CDATA[忽然，想去天津了]]></content:encoded><pubDate>Fri, 04 Jun 2021 11:33:27 +0800</pubDate></item><item><title>高通量原位DNA合成将国产化，国外标杆三年涨14倍</title><link>https://mp.weixin.qq.com/s/kczIjhAB_NGgb5Eqj61W4g</link><description></description><content:encoded><![CDATA[高通量原位DNA合成将国产化，国外标杆三年涨14倍]]></content:encoded><pubDate>Fri, 04 Jun 2021 11:33:27 +0800</pubDate></item><item><title>全自动创新型核酸检测企业艾科诺获数千万元A3轮融资</title><link>https://mp.weixin.qq.com/s/gkgMdLgzQhcdpz8MlO071A</link><description></description><content:encoded><![CDATA[全自动创新型核酸检测企业艾科诺获数千万元A3轮融资]]></content:encoded><pubDate>Fri, 04 Jun 2021 11:33:27 +0800</pubDate></item><item><title>先声诊断完成近六亿元B轮融资，中信证券投资及中信医疗基金领投</title><link>https://mp.weixin.qq.com/s/fYpTEUiwdnwmCL-PtXofSg</link><description></description><content:encoded><![CDATA[先声诊断完成近六亿元B轮融资，中信证券投资及中信医疗基金领投]]></content:encoded><pubDate>Fri, 04 Jun 2021 11:33:27 +0800</pubDate></item></channel></rss>